Trump Announces Phased Tariffs on Generic Medicines, Rising to 200%
US President Donald Trump announced steep tariffs on imported generic medicines, saying the aim is to bring pharmaceutical manufacturing back to the United States. Under the plan, from 1 August generic drugs entering the US would keep a zero per cent tariff for two years, then rise to 100% for a year, and to 200% from the third year onward. Trump said it carries a penalty for companies that choose not to build plants in the US, while the approach to patented and branded drugs stays unchanged. The move could hit India hard: often called the "pharmacy of the world," India exported $9.7 billion worth of pharmaceuticals to the US in 2025 — 38% of its total global pharma exports of $25.8 billion.
Key Facts & Details
8 points- 1Trump announced phased tariffs on imported generic medicines.
- 2From 1 August: 0% for two years, then 100% for a year, then 200%.
- 3The stated aim is to shift generic-drug manufacturing to the US.
- 4The approach to patented and branded drugs remains unchanged.
- 5India exported $9.7 billion of pharma to the US in 2025 — 38% of its global pharma exports.
Deep Dive
- +India is the largest exporter of generic drugs to the US.
- +India's total global pharma exports were $25.8 billion in 2025.
- +Indian generics widely treat blood pressure, diabetes, cancer and infectious diseases.
Exam Focus
Under Trump's announced plan, what is the eventual tariff rate on imported generic medicines?
Exam Relevance & Angle
US tariff decisions on generics directly affect India's pharmaceutical exports — a major foreign-exchange earner — making this high-yield trade and economy general awareness.
Target Exams
Background & Context
India is known as the "pharmacy of the world" because it supplies a very large share of the generic medicines used globally — drugs that are chemically identical to an original branded medicine but sold after its patent expires, and therefore far cheaper. The US is India's single biggest pharma market. Tariffs are taxes on imports; steep tariffs on generics would raise costs for US buyers and pressure Indian exporters, while aiming to push manufacturing onshore.
Test Yourself
1 / 2Under Trump's announced plan, the tariff on imported generic medicines eventually rises to:
Source
This topic is important for:
